New stem cell transplant study offers hope for blood cancer patients
NCT ID NCT03480360
First seen Feb 22, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tests a stem cell transplant using blood cells from a half-matched (haploidentical) donor for people with certain blood cancers like leukemia and lymphoma. The goal is to see if this approach helps patients survive longer and recover their immune system. The trial involves 21 participants and focuses on survival at 100 days and one year after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756, United States
Conditions
Explore the condition pages connected to this study.